| Symbol | CRTD |
|---|---|
| Name | CREATD INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 19904 United States DE 1111B S Governors Ave STE 20721 |
| Telephone | +1 646-859-5747 |
| Fax | — |
| — | |
| Website | https://creatd.com/ |
| Incorporation | US |
| Incorporated On | 1999 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Astra Audit & Advisory, LLC; |
| Audit Status | AUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001357671 |
| Description | Creatd builds, operates, and scales innovative businesses across technology, media, advertising, data, and consumer sectors. It blends creative vision with operational expertise to create value-driven opportunities that empower businesses and individuals alike. Its portfolio includes ventures such as Vocal, a robust platform enabling creators to share stories and connect with engaged audiences, and OG Collection, which transforms archival content into modern, monetizable assets, among other portfolio companies. Creatd integrates these ventures into a cohesive strategy, leveraging proprietary technology, first-party data insights, and deep market knowledge to drive sustainable growth and impactful results. Creatds creator-first approach is the foundation of our culture and purpose, influencing every decision we make. We leverage first-party data to assist our portfolio companies in enhancing content creation, audience interaction, and brand campaigns, ensuring authentic and impactful engagement. This fosters a dynamic ecosystem where insights and resources from one portfolio company benefit others, creating a positive feedback loop. Our integrated business model combines technology, advertising, media, e-commerce, and data, driving continuous value and innovation. Through strategic acquisitions and partnerships, Creatd seeks to expand its influence, unlocking potential and delivering value for shareholders and the wider creative community. Additional info from OTC: |